Ownership Summary
A total of 7 institutions have reported a stake in PureTech Health plc (NASDAQ:PRTC) as of September 2025, according to recent 13F filings with the SEC.
- Institutional ownership in PureTech Health edged up to 5.9% in September 2025, compared to 0.1% in June 2025.
- Institutional share ownership changed by 17042.26% QoQ, while the number of institutional owners saw an increase of 75.00% YoY.
- The latest 13F cycle for PureTech Health reveals that of 7 total investors, 3 funds grew their exposure, whereas 1 reduced theirs and 3 made no changes.
- Collectively, institutional investors increased their stake in PureTech Health to 14.21Mn shares as of September 2025, a change that is up by 14.13Mn shares quarter on quarter and up 14.18Mn shares year over year.
- LANSDOWNE PARTNERS (UK) LLP's holding of 14.11Mn shares as of September 30, 2025 makes it the primary institutional investor in PureTech Health, owning 5.89% of the stock.
- Among the most significant buyers of PureTech Health during September 2025 were LANSDOWNE PARTNERS (UK) LLP (14.11Mn), Pentwater Capital Management LP (25.00K), SBI Securities Co., Ltd. (2).
- Leading sellers of PureTech Health stock in September 2025 included MILLENNIUM MANAGEMENT LLC (6.02K).
- The top 7 institutional holders of PureTech Health for the quarter ending September 2025 included LANSDOWNE PARTNERS (UK) LLP (14.11Mn), Pentwater Capital Management LP (75.00K), MILLENNIUM MANAGEMENT LLC (17.84K), DIADEMA PARTNERS LP (7.32K), Persistent Asset Partners Ltd (1.69K), UBS Group AG (20), SBI Securities Co., Ltd. (2).